Systematic and audiological indication criteria for bone conduction devices and active middle ear implants
- PMID: 34987018
- DOI: 10.1016/j.heares.2021.108424
Systematic and audiological indication criteria for bone conduction devices and active middle ear implants
Abstract
Certain patients with conductive or mixed hearing loss can benefit from bone-conduction hearing devices or active middle ear implants. Available devices differ in coupling site, energy transfer from the sound processor to the implant, and the active or passive actuator technology. The audiological benefit of those devices depends on the maximum stable power output and the noise floor of the device, the degree and expected stability of the sensorineural hearing loss and the coupling efficiency with the aim on achieving a minumum of 30-35 dB effective dynamic range. The choice of the device is often a trade-off between the optimal audiological solution with respect to the hearing loss, technical device-related parameters and the expected coupling efficiency, the optimal surgical solution with respect to patho-anatomical aspects, device dimensions and the coupling site, invasiveness or surgical risks, and other patient factors with respect to the patients' wish and expectations, social aspects, device usability and connectivity. This review article lists all currently available implantable and conventional bone-conduction hearing devices and active middle ear implants with respect to technical features like maximum power output, market availability, and the expected effective output dynamic range.
Keywords: Active hearing implant; Conductive hearing loss; Gain; Maximum power output; Mixed hearing loss.
Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.
Similar articles
-
Implantable Devices for Single-Sided Deafness and Conductive or Mixed Hearing Loss: A Health Technology Assessment.Ont Health Technol Assess Ser. 2020 Mar 6;20(1):1-165. eCollection 2020. Ont Health Technol Assess Ser. 2020. PMID: 32194878 Free PMC article.
-
Consensus Statement on Bone Conduction Devices and Active Middle Ear Implants in Conductive and Mixed Hearing Loss.Otol Neurotol. 2022 Jun 1;43(5):513-529. doi: 10.1097/MAO.0000000000003491. Epub 2022 Apr 4. Otol Neurotol. 2022. PMID: 35383700
-
Long-term data of the new transcutaneous partially implantable bone conduction hearing system Osia®.Eur Arch Otorhinolaryngol. 2022 Sep;279(9):4279-4288. doi: 10.1007/s00405-021-07167-9. Epub 2021 Nov 18. Eur Arch Otorhinolaryngol. 2022. PMID: 34792628 Free PMC article.
-
Safety and effectiveness of the Vibrant Soundbridge in treating conductive and mixed hearing loss: A systematic review.Laryngoscope. 2016 Jun;126(6):1451-7. doi: 10.1002/lary.25670. Epub 2015 Oct 15. Laryngoscope. 2016. PMID: 26468033 Review.
-
[Device-based treatment of mixed hearing loss: An audiological comparison of current hearing systems].HNO. 2016 Feb;64(2):91-100. doi: 10.1007/s00106-015-0087-5. HNO. 2016. PMID: 26601668 Review. German.
Cited by
-
Evaluating temporal bone column density for optimized bone conduction implant placement.Front Surg. 2023 Nov 30;10:1293616. doi: 10.3389/fsurg.2023.1293616. eCollection 2023. Front Surg. 2023. PMID: 38098476 Free PMC article.
-
Hearing rehabilitation with Baha® transcutaneous and percutaneous systems.Codas. 2023 Oct 23;36(1):e20220271. doi: 10.1590/2317-1782/20232022271pt. eCollection 2023. Codas. 2023. PMID: 37878957 Free PMC article.
-
Prediction of postoperative speech comprehension with the transcutaneous partially implantable bone conduction hearing system Osia®.HNO. 2024 Jan;72(Suppl 1):1-9. doi: 10.1007/s00106-023-01337-3. Epub 2023 Oct 9. HNO. 2024. PMID: 37812258 Free PMC article.
-
[Prediction of speech understanding with the transcutaneous partially implantable bone conduction hearing system Osia®. German Version].HNO. 2023 Aug 17. doi: 10.1007/s00106-023-01336-4. Online ahead of print. HNO. 2023. PMID: 37589726 German.
-
Bone Conduction Threshold Measurements in Patients with Bone Conduction Devices: A Comparison of Available Methods.J Int Adv Otol. 2023 Jul;19(4):288-294. doi: 10.5152/iao.2023.22734. J Int Adv Otol. 2023. PMID: 37528593 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
